SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (316)11/14/2005 8:39:59 PM
From: tuck  Read Replies (1) of 447
 
Actually listened to the CC myself. Not sure what the Yahoo poster that dissed Goddard's response was talking about, but he knows Goddard's speaking style far better than I. Ricardouno, who is kind enough to post scrip data, opined that Goddard's response was tongue tied, etc. Goddard was asked why there were not numbers modeling Lucentis' impact already run, like before the merger was announced, and available to the public now. I'd say that Goddard's reply was about as good as could be expected given how stupid this deal makes the company look.

Anyhow, next Monday we get a far more comprehensive update. This was just a rah rah PR/CC with only that one question, asked by Ende of ML.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News